EPO Patents = 2

Forward Citations = 4

Loading Chart...

8 inventors (with patents filed for the assignee):

Francesco Bertoni (2 out of 6 patents)

Kay Noel (2 out of 2 patents)

Maria Eugenia Riveiro (2 out of 4 patents)

4. Maurizio D'Incalci (1 out of 1 patent)

5. Eric Raymond (1 out of 3 patents)

6. Paola Bonetti (0 patent)

7. Jeff Gautschi (0 patent)

8. Ryan Minikis (0 patent)

4 patents: Sort by Forward Citations

1. 9968620 - Methods of treating lymphoma using thienotriazolodiazepine compounds (2018-05-15),

2. 9968619 - Method of treating triple-negative breast cancer using thienotriazolodiazepine compounds (2018-05-15),

3. 9956228 - Method of treating acute myeloid leukemia and/or acute lymphoblastic leukemia using thienotriazolodiazepine compounds (2018-05-01),

4. 9901583 - Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compounds (2018-02-27),

Oncoethix GmbH is a biotech company focused on developing innovative cancer therapies. With a strong team of scientists and researchers, Oncoethix is dedicated to advancing precision medicine in oncology through cutting-edge research and personalized treatment approaches. The company's mission is to improve outcomes for cancer patients by harnessing the power of targeted therapies and novel treatment modalities.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4 Patents

#18 in Lucerne

#1,951 in Switzerland

Lucerne, Switzerland

Oncoethix Gmbh